TY  - GEN
AU  - Charmsaz,S
AU  - Al-Ejeh,F
AU  - Yeadon,T M
AU  - Miller,K J
AU  - Smith,F M
AU  - Stringer,B W
AU  - Moore,A S
AU  - Lee,F-T
AU  - Cooper,L T
AU  - Stylianou,C
AU  - Yarranton,G T
AU  - Woronicz,J
AU  - Scott,A M
AU  - Lackmann,M
AU  - Boyd,A W
TI  - EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia
SN  - 1476-5551
PY  - 2017///1009
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Bismuth
KW  - Cell Line, Tumor
KW  - Humans
KW  - Immunotherapy
KW  - Mice
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Receptor, EphA3
KW  - immunology
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2016.371
ER  -